Trevi Therapeutics to Participate in Upcoming July Investor Events ...Middle East

PR Newswire - News
Trevi Therapeutics to Participate in Upcoming July Investor Events
NEW HAVEN, Conn., July 6, 2023 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for difficult to treat patients with chronic cough in idiopathic pulmonary fibrosis...

Hence then, the article about trevi therapeutics to participate in upcoming july investor events was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Trevi Therapeutics to Participate in Upcoming July Investor Events )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News